GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE)

CUSIP: 37185R208

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / SPON ADR 150SHS
Total 13F shares
627,794
Share change
-54,582
Total reported value
$341,290
Price per share
$0.54
Number of holders
8
Value change
-$41,264
Number of buys
2
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 37185R208?
CUSIP 37185R208 identifies GENE - GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) as of Q4 2018

As of 31 Dec 2018, GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 627,794 shares. The largest 8 holders included RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, Cambridge Investment Research Advisors, Inc., Cutler Group LP, UBS Group AG, Federation des caisses Desjardins du Quebec, and BREWIN DOLPHIN Ltd. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.